Comparison of Clinical Characteristics between Pulmonary Tuberculosis Patients with Extensively Drug-resistance and Multi-drug Resistance at National Medical Center in Korea.
10.4046/trd.2008.64.6.414
- Author:
Chong Kyung KIM
1
;
Ha Do SONG
;
Dong Il CHO
;
Nam Soo YOO
Author Information
1. Department of Chest Medicine, National Medical Center, Seoul, Korea. ps24k@hanmail.net
- Publication Type:Original Article
- Keywords:
Extensively drug-resistant tuberculosis;
Multi-drug resistant tuberculosis;
Drug susceptibility test
- MeSH:
Diabetes Mellitus;
Drug Resistance;
Drug Resistance, Multiple;
Extensively Drug-Resistant Tuberculosis;
Humans;
Korea;
Logistic Models;
Male;
Medical Records;
Public Health;
Retrospective Studies;
Sputum;
Thorax;
Tuberculosis, Multidrug-Resistant;
Tuberculosis, Pulmonary
- From:Tuberculosis and Respiratory Diseases
2008;64(6):414-421
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Recently, in addition to multi-drug resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB) has become rapidly growing public health threat. This study examined the clinical differences between pulmonary TB patients with extensively drug resistance (XDR) and multi-drug resistance (MDR) at the National Medical Center in Korea in order to determine the clinical characteristics associated more with XDR-TB than MDR-TB. METHODS: Patients who received a diagnosis of culture-confirmed pulmonary TB and a drug sensitivity test (DST) for anti-TB drugs at the National Medical Center between January 2000 and August 2007 were enrolled in this study. The patients were identified into the XDR-TB or MDR-TB group according to the DST results. The clinical characteristics were reviewed retrospectively from the medical records. Statistical analysis for the comparisons was performed using a chi-square-test, independent samples t-test or binary logistic regression where appropriate. RESULTS: A total 314 patients with culture-confirmed pulmonary TB were included. Among them, 18 patients (5.7%) had XDR-TB and 69 patients (22%) had MDR-TB excluding XDR-TB. A comparison of the clinical characteristics, revealed the XDR-TB group to have a higher frequency of a prior pulmonary resection for the treatment of TB (odds ratio [OR], 3.974; 95% confidence interval [CI], 1.052~15.011; P value 0.032) and longer average previous treatment duration with anti-TB drugs, including a treatment interruption period prior to the diagnosis of XDR, than the MDR-TB group (XDR-TB group, 72.67 months; MDR-TB group, 13.09 months; average treatment duration difference between two groups, 59.582 months; 95% CI, 31.743~87.420; P value, 0.000). In addition, a longer previous treatment duration with anti-TB drugs was significantly associated with XDR-TB (OR, 1.076; 95% CI, 1.038~1.117; P value, 0.000). A comparison of the other clinical characteristics revealed the XDR-TB group to have a higher frequency of male gender, diabetes mellitus (DM), age under 45, treatment interruption history, cavitations on simple chest radiograph and positive result of sputum AFB staining at the time of diagnosis of XDR. However, the association was not statistically significant. CONCLUSION: Pulmonary TB patients with XDR have a higher frequency of a prior pulmonary resection and longer previous treatment duration with anti-TB drugs than those with MDR. In addition, a longer previous treatment duration with anti-TB drugs is significantly associated with XDR-TB.
